���重受体激动剂的分子设计 — Research Overview

By Editorial Desk · published 2026-05-24 · last reviewed 2026-06-11 · News

If you have been reading about 肽类药物 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.

Last reviewed on 2026-06-11. Where a claim depends on a specific study, the study is described rather than over-claimed.

三重受体激动剂的分子设计

该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。

retatrutide 是一种人工合成的多肽，设计目标是同时作用于 GIP、GLP-1 与胰高血糖素三种受体。这种三重激动设计试图把多条代谢通路的调节整合进单一分子，而不是只依赖一种肠促胰素受体。分子骨架以天然肽序列为基础，经过非天然氨基酸替换和脂肪酸侧链修饰，以获得更长的作用时间。该方向属于多受体激动剂研究的一部分，与双重激动剂的工作并行推进。

Triple Receptor Agonist Background

Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.

Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.

Retatrutide at a glance

Laboratory Handling and Analysis

Stability studies examine how the molecule changes under defined conditions of temperature, humidity, and light exposure over time. Results are used to set storage recommendations and shelf-life limits. In practice, lyophilized peptide material is often stored at low temperatures to slow degradation, while reconstituted solutions are handled more carefully because they are generally less stable. Reported stability data apply to specific formulations and conditions, so extrapolation to other preparations requires caution.

Retatrutide is handled in laboratories mainly as a lyophilized solid for analytical and biochemical research. The peptide is typically supplied as a white to off-white powder and is reconstituted in appropriate solvents before use. Because peptide-based molecules are sensitive to temperature, moisture, and repeated freeze-thaw cycles, proper storage conditions affect both stability and measurement accuracy. Laboratories generally follow documented handling procedures to maintain the integrity of the material across experiments.

Identification and purity assessment rely on established analytical techniques. Reverse-phase high-performance liquid chromatography separates the compound from related impurities and degradation products. Mass spectrometry confirms molecular identity and detects modifications that change the expected mass. Additional methods such as amino acid analysis or capillary electrophoresis may be used for verification. Small differences in sample preparation can influence results, so procedures are usually controlled and documented in detail. Consistency between runs supports confidence in reported values.

Related pages on this site

• Modern collection
• Gradual playbook
• Material primer
• Proven index
• Material primer
• Material guide
• Quality handbook
• Modern primer

Retatrutide Background and Design

The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.

Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.

Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.

Analytical Methods and Storage Practice

Characterization panels may add amino acid analysis for compositional confirmation, circular dichroism for secondary structure in solution, and light scattering for aggregation tendency. Aggregation is a central concern for peptides bearing hydrophobic side chains, since it can lower measured potency and complicate accurate dosing. Stability studies examine temperature, humidity, pH, and light exposure over defined intervals, reporting the percentage of intact peptide remaining. Results depend strongly on the assay used, so comparing values across studies requires matching method details.

Peptide content and purity are commonly measured by reversed-phase high-performance liquid chromatography with ultraviolet detection, using gradient elution over a C18 column. Identity is confirmed by mass spectrometry, because the theoretical monoisotopic mass allows unambiguous assignment of the main component. Impurity profiling resolves deletion sequences, oxidized residues, and truncated fragments. Since the molecule carries a lipophilic side chain, mobile phases often include ion-pairing agents and organic modifiers to keep peaks symmetric.

Molecular Identity and Receptor Targets

Each receptor contributes a different physiological effect. Activation of the GLP-1 receptor slows gastric emptying and reduces appetite signaling in the brain. GIP receptor activity influences insulin secretion and lipid handling, while glucagon receptor stimulation raises energy use and fat oxidation. Combining these pathways is intended to produce weight loss beyond what single- or dual-receptor agonists achieve. Researchers attribute the observed potency to simultaneous engagement of all three targets, though the exact contribution of each receptor to overall effect remains under investigation.

Clinical development has advanced through phase 2 trials in adults with obesity and type 2 diabetes. Reported phase 2 results described substantial average weight reduction over roughly forty-eight weeks of weekly dosing. A phase 3 program is ongoing to confirm efficacy and assess long-term safety. Because the compound has not received regulatory approval, it is not available as a prescription product. Public discussion of retatrutide often conflates trial findings with marketed status, an important distinction when interpreting coverage of the topic.

Background from the literature

Tyrannosaurus lived during what is referred to as the Lancian faunal stage (Maastrichtian age) at the end of the Late Cretaceous. Tyrannosaurus ranged from Canada in the north to at least New Mexico in the south of Laramidia. Several notable Tyrannosaurus remains have been found in the Hell Creek Formation. During the Maastrichtian this area was maritime to subtropical, with a warm and humid climate. The flora consisted mostly of angiosperms, but also included trees like dawn redwood (Metasequoia). Archosaurs discovered from this formation include the ceratopsians Leptoceratops, Torosaurus, and Triceratops, the hadrosaurid Edmontosaurus annectens, the parksosaurid Thescelosaurus, the ankylosaurs Ankylosaurus and Denversaurus, the pachycephalosaurs Pachycephalosaurus, Platytholus and Sphaerotholus, the paravian theropods Acheroraptor and Pectinodon, other maniraptoran theropods Anzu, Eoneophron, Trierarchuncus and indeterminate ornithomimids, the tyrannosauroid Nanotyrannus, and the azhdarchid pterosaur Infernodrakon.

=== Mobility === People with mild (type I) OI as adults need few pieces of adaptive equipment, although in infancy they reach motor milestones at a significant delay compared to the general population. With adaptive equipment such as crutches, motorized wheelchairs, splints, reach extenders, and/or modifications to the home, many individuals with moderate to severe OI can achieve or maintain a significant degree of independence. With treatment and physical therapy, the maximum levels of mobility are expected to be unassisted community walking for type I, household or exercise walking for type III, and household or community walking for type IV; due to the variability of OI between individuals, mobility achieved varies and may be below this expected maximum.

=== Sexual Dysfunction === SNRIs, similarly to SSRIs, can cause several types of sexual dysfunction, such as erectile dysfunction, decreased libido, sexual anhedonia, and anorgasmia. The two common sexual side effects are diminished interest in sex (libido) and difficulty reaching climax (anorgasmia), which are usually somewhat milder with SNRIs compared to SSRIs. To manage sexual dysfunction, studies have shown that switching to or augmenting with bupropion or adding a PDE5 Inhibitor have decreased symptoms of sexual dysfunction. Studies have shown that PDE5 Inhibitors, such as sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra), have sometimes been helpful to decrease the sexual dysfunction, including erectile dysfunction, although they have been shown to be more effective in men than women.

Albumin-bound paclitaxel (brand name Abraxane, also called nab-paclitaxel) is an alternative formulation where paclitaxel is bound to albumin nanoparticles. Much of the clinical toxicity of paclitaxel is associated with the solvent Cremophor EL in which it is dissolved for delivery. Abraxis BioScience developed Abraxane, in which paclitaxel is bonded to albumin as an alternative delivery agent to the often toxic solvent delivery method. This was approved by the FDA in January 2005, for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within six months of adjuvant chemotherapy. It has since been approved for locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas as well. Taxanes, including paclitaxel, 10-deacetylbaccatin III, baccatin III, paclitaxel C, and 7-epipaclitaxel, have been found in the leaves and shells of hazel. The finding of these compounds in shells, which are considered discarded material and are mass-produced by many food industries, is of interest for the future availability of paclitaxel.

Associated material may include field notes, drawings, photographs, spore prints, and permanent slide mounts, and the papers, labels, adhesives, and plastics used in storage are ideally archival quality to limit long-term deterioration. Historically, some curators prepared fleshy fungi as pressed longitudinal sections mounted on herbarium sheets and enclosed in packets, a method that saved space and could preserve gross form better than conventional box-dried specimens; additional dried fragments could be included for later microscopic study. For delicate, fragile, or deliquescent fungi, preservation has sometimes relied on dried sections or illustrations mounted on absorbent paper to retain at least some diagnostic morphological characters. For each specimen, records commonly include the collector, collection date, locality, identifier, later revisions, and notes on biotope and substrate. For newer specimens, locality data may include geographic coordinates so that collection sites can be revisited. In many collections, specimens are arranged alphabetically by genus and species and tracked in electronic collection databases. No single arrangement scheme is used in all fungaria: smaller collections may be arranged alphabetically by genus and species, whereas larger ones may place specimens in taxonomic order by major groups and then alphabetically within genera; within a species, material may also be arranged by host or geography to aid retrieval.

Sources: en.wikipedia.org

Reference notes

Physicians have been advised to help patients interested in looksmaxxing to distinguish between safe beauty practices and harmful practices, suggesting to patients to only conduct looksmaxxing practices when done in a medically viable manner. Clavicular's system of rating looksmaxxing that he promotes in interviews and on social media is the PSL scale, which gives men a numerical rating then sorts men into three tiers: "subhuman", "normie", and "Chad". In her New Yorker criticism, journalist Becca Rothfeld explains, "The moral objections to looksmaxxing are numerous, severe, and obvious. A system that designates any person as 'subhuman' is beneath contempt, and that's to say nothing of the racial slurs to which looksmaxxing stalwarts help themselves regularly." She also cites a recent interview in which Clavicular "approvingly notes that Brad Pitt 'mogs' Mother Teresa". While its encouragement for men to care about their health and fitness can be seen as a positive, looksmaxxing overall is seen as demoralising to men, especially the young. A study published in the National Library of Medicine argues that looksmaxxing promotes a hegemonic masculine gaze on male bodies. Hegemonic masculinity is a social concept developed by R. W. Connell that defines the ideal form of dominant and physically attractive male bodies, legitimizes sexism, and reinforces patriarchy. The study's findings support its argument, and proves that the looksmaxxing community revolves around male supremacy and hegemonic masculinity.

In 1857, the American Watch Company in Waltham, Massachusetts, introduced the Waltham Model 57, the first to use interchangeable parts. This cut the cost of manufacture and repair. Most Model 57 pocket watches were in a coin silver ("one nine fine"), a 90% pure silver alloy commonly used in dollar coinage, slightly less pure than the British (92.5%) sterling silver, both of which avoided the higher purity of other types of silver to make circulating coins and other utilitarian silver objects last longer with heavy use.

If untreated, the bacteria may persist in the body for months or even years, despite the production of B. burgdorferi antibodies by the immune system. The spirochetes may avoid the immune response by decreasing expression of surface proteins that are targeted by antibodies, antigenic variation of the VlsE surface protein, inactivating key immune components such as complement, and hiding in the extracellular matrix, which may interfere with the function of immune factors.

The calculations to be performed on the measurements taken depend on the technology used, since beta counters measure the sample's radioactivity whereas AMS determines the ratio of the three different carbon isotopes in the sample. To determine the age of a sample whose activity has been measured by beta counting, the ratio of its activity to the activity of the standard must be found. To determine this, a blank sample (of old, or dead, carbon) is measured, and a sample of known activity is measured. The additional samples allow errors such as background radiation and systematic errors in the laboratory setup to be detected and corrected for. The most common standard sample material is oxalic acid, such as the HOxII standard, 1,000 lb of which was prepared by the National Institute of Standards and Technology (NIST) in 1977 from French beet harvests. The results from AMS testing are in the form of ratios of 12C, 13C, and 14C, which are used to calculate Fm, the "fraction modern". This is defined as the ratio between the 14C/12C ratio in the sample and the 14C/12C ratio in modern carbon, which is in turn defined as the 14C/12C ratio that would have been measured in 1950 had there been no fossil fuel effect. Both beta counting and AMS results have to be corrected for fractionation. This is necessary because different materials of the same age, which because of fractionation have naturally different 14C/12C ratios, will appear to be of different ages because the 14C/12C ratio is taken as the indicator of age.

=== Initial analogue development (1996–2014) === The development of insulin analogues began with Humalog (insulin lispro), a short-acting insulin analogue developed by Eli Lilly, which was approved by the FDA in 1996. Humalog was designed to be absorbed more quickly than regular insulin, offering improved flexibility in meal timing and postprandial glucose control. In 2000, Lantus (insulin glargine) was approved by the FDA and the European Medicines Agency (EMA). Lantus is a long-acting insulin analogue designed to provide a steady basal level of insulin throughout the day, typically lasting up to 24 hours, thereby reducing the need for multiple daily injections. In 2004, Apidra (insulin glulisine), another short-acting insulin analog, was approved by Sanofi-Aventis to improve postprandial glucose control. In 2005, Levemir (insulin detemir), developed by Novo Nordisk, was approved for clinical use. Levemir is a long-acting insulin analogue similar to Lantus but with a slightly shorter duration of action. It provides stable basal insulin coverage with a reduced risk of hypoglycemia compared to older insulins.

Sources: en.wikipedia.org

Reference notes

In late August 2008, Georgian president Saakashvili said that he expected threat from Abkhazia and had most of the forces stationed near Abkhazia, adding: "if we'd intended to attack, we'd have withdrawn our best-trained forces from Iraq up front." He also said that he had been told in Dubrovnik that Russia would attack Georgia in the summer of 2008. By late August, President Saakashvili said that before the war, he had warned Western leaders (among them U.S. Secretary of State Condoleezza Rice and German Chancellor Angela Merkel) about Russia's intentions to invade Georgia; however his warnings were not taken into account. The Georgian authorities were aware that the United States would not become militarily involved in the conflict with Russia. On 31 August, President Saakashvili told the CNN that he supported neutral international investigation into the causes of the war. He further said that Putin had threatened with the war in the fall of 2006 before the announcement of trade embargo against Georgia. In September 2008, former Russian president Vladimir Putin said the war began during the second half of 7 August and Russian military reached Tskhinvali in two days. Putin accused the United States of encouraging Georgian military attack. He added, "When an aggressor comes into your territory, you need to punch him in the face." Putin claimed there would be a "second blow" into the North Caucasus if Russia had not acted in Georgia.

=== Market withdrawal === Conjugated estrogens oral (Cenestin; synthetic conjugated estrogens) – estrogen (estrogen receptor agonist) – atrophic vaginitis [153] Testosterone transdermal (Intrinsa; Intrinsa CHF; Livensa; Testosterone transdermal TheraDerm MTX; WC3048; WC3049) – androgen (androgen receptor agonist) – female sexual dysfunction [154]

== DHIS2 software == As a digital solution for data collection and management, DHIS2 can be used for aggregate data (e.g. routine health facility data, staffing, equipment, infrastructure, population estimates, etc.), event data (e.g. disease outbreaks, survey/audit data, patient satisfaction surveys, etc.), and individual-level longitudinal data (e.g. vaccination records, lab sample collection and testing, patient treatment and follow-up, student progress, etc.). The system supports the capture of data linked to any level in an organizational hierarchy at any data collection frequency. DHIS2 includes built-in tools for analytics, including dashboards, charts, pivot tables and maps, as well as data validation and data quality features. It also includes tools to support collaborative data use, such as sharing, commenting and interpretation. The DHIS2 platform can be extended with custom applications (which can be published and shared through the DHIS2 App Hub) or integrated with third-party software or external data sources through the open web API. DHIS2 supports health data standards such as FHIR, SNOMED GPS, LOINC, and ICD-11, as well as the generic ADX format for aggregate data exchange. The DHIS2 data model and platform are generic by design, not specifically tailored to the health context, to facilitate the application of DHIS2 to a variety of use cases. DHIS2 is a web-based platform. The core software and database are hosted on a server, which can be either physically located in the country of ownership or cloud-based.

This direct and indirect economic contraction caused the city to lose property taxes, wage taxes, and population (and thus consumer demand). The closed auto plants were also often abandoned in a period before strong environmental regulation, causing the sites to become so-called "brownfields", unattractive to potential replacement businesses because of the pollution hangover from decades of industrial production. The pattern of the deteriorating city by the mid-1960s was visibly associated with the largely departed auto industry. The neighborhoods with the most closed stores, vacant houses, and abandoned lots were in what had formerly been the most heavily populated parts of the city, adjacent to the now-closed older major auto plants. By the 1970s and 1980s, the auto industry suffered setbacks that further impacted Detroit. The industry encountered the rise of OPEC and the resulting sharp increase in gasoline prices. It faced new and intense international competition, particularly from Italian, Japanese and German automobile manufacturers. Chrysler avoided bankruptcy in the late 1970s only with the aid of a federal bailout. GM and Ford also struggled financially. It also relocated ever more of its manufacturing to lower-cost states in the U.S. and to low-income countries. Detroit's residents thus had access to fewer and fewer well-paying, secure auto manufacturing jobs. The leadership of Detroit failed to diversify the city's industry beyond automotive manufacturers and related industries.

Sources: en.wikipedia.org

Frequently asked questions